Archives     Advertise     Editorial Calendar     Subscribe     Contact Us    

DOJ Formalizes New Approach to Frivolous Qui Tam Actions


Last month we reported that Michael Granston, director of the Civil Fraud Section of the Department of Justice (DOJ), made comments during a November 2017 healthcare compliance conference suggesting that in cases where the DOJ has determined allegations in a qui tam (or "whistleblower") lawsuit lack merit, the government might more aggressively exercise its statutory authority - rarely used in the past - to dismiss such cases. In a formal memorandum released on Jan. 10, 2018, Director Granston put those words to action.

In his memo, Granston acknowledges that although the DOJ has seen "record increases" over the last few years in qui tam actions filed under the False Claims Act, it has "sparingly" utilized its authority to dismiss those lawsuits following its decision not to intervene. As a result, the government has "expend[ed] significant resources" in continuing to monitor these cases. In light of that, the memo encourages prosecutors to more carefully consider the prospect of dismissing qui tam lawsuits where the government opts not to intervene (which, as explained last month, occurs in approximately 75 percent of these cases).

The memo then identifies seven factors that prosecutors should consider when evaluating whether to seek dismissal:

  1. Curbing meritless qui tam lawsuits - where the complaint is "facially lacking in merit" because of a defective legal theory or frivolous factual allegations;
  2. Preventing parasitic or opportunistic qui tam lawsuits - where the lawsuit duplicates a pre-existing investigation and adds no useful information to the investigation;
  3. Preventing interference with agency policies and programs - where an agency has determined that a qui tam lawsuit threatens to interfere with the agency's policies or the administration of its program and has recommended dismissal to avoid these effects;
  4. Controlling litigation brought on behalf of the government - when necessary to protect the DOJ's litigation prerogatives;
  5. Safeguarding classified information and national security interests - particularly in cases involving intelligence agencies or military procurement contracts;
  6. Preserving government resources - when the government's costs are likely to exceed any expected gain, such as when the estimated government losses are less than the anticipated burden imposed on taxpayers by continued governmental participation even when the relator advances the litigation; and
  7. Addressing egregious procedural errors - where there are problems with the relator's lawsuit that frustrate the government's efforts to conduct a proper investigation, such as when the relator fails to serve the qui tam complaint or disclose material facts to the government.

The memo goes on to provide other practical guidance to prosecutors and, among other things, advises that the seven factors are not exhaustive, and there may be other factors that could be considered in determining whether to dismiss a case.

The memo reminds prosecutors that they can seek partial - as opposed to wholesale - dismissal of qui tam complaints and also instructs prosecutors to "consider advising relators of perceived deficiencies in their cases, as well as the prospect of dismissal" so that relators could consider dismissing the lawsuit on their own. According to the memo, since January 2012, relators have dismissed over 700 qui tam lawsuits voluntarily after learning that the DOJ was declining to intervene.

The Granston memo is significant because it marks the first time in the DOJ's history that it has issued written guidance on this matter. As a result, healthcare providers who find themselves defending a meritless qui tam action now have a blueprint - through the DOJ's seven guideposts - in arguing for its dismissal.

Although the practical impact of the memo remains to be seen, at the very least it reflects the DOJ's willingness to dismiss burdensome and frivolous whistleblower lawsuits. In the end, it might turn out that the memo will not result in many more dismissals by the DOJ itself, but rather in more voluntary dismissals by relators who learn of the "perceived deficiencies in their cases" and the "prospect of dismissal." Either scenario would be welcome news to healthcare companies that spend millions of dollars every year defending meritless whistleblower lawsuits.

J. Matthew Kroplin is a partner in Burr & Forman's Nashville office, practicing in the firm's healthcare and business litigation sections. Adam W. Overstreet is counsel in Burr & Forman's Birmingham office, practicing in the firm's healthcare section, and is a former Assistant United States Attorney.


Burr & Forman



Related Articles:

Recent Articles

Trump Administration Announces MyHealthEData Initiative to Put Patients at the Center of the US Healthcare System

CMS launches "Blue Button 2.0" tool, calls on all health insurers to make data available to patients

Read More

Centauri Health Solutions Partners with RoundTrip, Lyft for RISE Nashville Summit

Partnership providing free rides via Lyft code or RoundTrip app to showcase link between transportation and quality healthcare

Read More

Assessing and Addressing Detriments to Health in Nashville

From safer sidewalks to anti-smoking campaigns, Nashville is finding innovative ways to address social detriments in Middle Tennessee.

Read More

Password Protected

Trying to stay ahead of healthcare hacks can be time consuming and costly. Yet, many medical practices and healthcare companies could significantly lower risks by following simple, inexpensive best practices.

Read More

Dr. Kiffany Peggs: Changing Expectations

Geriatrician Kiffany Peggs' whole-person approach brings peace of mind, hope to UnitedHealthcare clients.

Read More

Driving Community Outcomes

Two area companies are doing their part to highlight and address common barriers to care that increase health risks in American communities.

Read More

Better Collaboration Required to Address Social Determinants

Despite amazing advances in medical science and improved understanding of biology on a cellular level, environment continues to play the biggest role in impacting an individual's health status.

Read More

Mazzetti+GBA Helps Bring Clean Water to Puerto Rico

Mazzetti+GBA believes in building healthier environments to make the world a better place - whether that environment is a hospital in a small Tennessee town or a community clinic in rural Burundi.

Read More

Heart Failure Risk Predicted By Communities, Not Wealth

When buying and selling real estate, how often have you heard the realtor's mantra-- location, location, location? This is also the central theme of a recently released journal report on factors that can predict heart failure risk.

Read More

Walking in a Patient's Shoes

What happens when the 'right' action plan for a diagnosis doesn't mesh with the real world? UTHSC students and residents in Chattanooga have a unique opportunity to walk in their patients' shoes.

Read More

Email Print



Adam Overstreet, Burr & Forman, False Claims Act, Granston Memo, Matthew Kroplin, Michael Granston, Qui Tam, Whistleblower
Powered by Bondware
News Publishing Software

The browser you are using is outdated!

You may not be getting all you can out of your browsing experience
and may be open to security risks!

Consider upgrading to the latest version of your browser or choose on below: